Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 0 | $0 |
Sells | 322 | $203,380,051 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
04 May 2022 17:21 | VRTX | VERTEX PHARMACEUTICALS INC | ARBUCKLE STUART A | EVP, COO | 02 May 2022 | Sale | 306 | 263.98 | 80,778 | D |
04 May 2022 17:10 | VRTX | VERTEX PHARMACEUTICALS INC | SANNA BASTIANO | EVP, Cell & Genetic Therapies | 02 May 2022 | Sale | 4 | 264.37 | 1,057 | D |
04 May 2022 17:10 | VRTX | VERTEX PHARMACEUTICALS INC | SANNA BASTIANO | EVP, Cell & Genetic Therapies | 02 May 2022 | Sale | 65 | 261.79 | 17,016 | D |
04 May 2022 17:10 | VRTX | VERTEX PHARMACEUTICALS INC | SANNA BASTIANO | EVP, Cell & Genetic Therapies | 02 May 2022 | Sale | 23 | 260.44 | 5,990 | D |
04 May 2022 17:10 | VRTX | VERTEX PHARMACEUTICALS INC | SANNA BASTIANO | EVP, Cell & Genetic Therapies | 02 May 2022 | Sale | 75 | 259.58 | 19,468 | D |
04 May 2022 17:10 | VRTX | VERTEX PHARMACEUTICALS INC | SANNA BASTIANO | EVP, Cell & Genetic Therapies | 02 May 2022 | Sale | 43 | 258.46 | 11,114 | D |
04 May 2022 17:10 | VRTX | VERTEX PHARMACEUTICALS INC | SANNA BASTIANO | EVP, Cell & Genetic Therapies | 02 May 2022 | Sale | 90 | 257.49 | 23,174 | D |
04 May 2022 17:10 | VRTX | VERTEX PHARMACEUTICALS INC | SANNA BASTIANO | EVP, Cell & Genetic Therapies | 02 May 2022 | Sale | 20 | 255.47 | 5,109 | D |
04 May 2022 17:09 | VRTX | VERTEX PHARMACEUTICALS INC | BHATIA SANGEETA N. | Director | 02 May 2022 | Sale | 6 | 264.37 | 1,586 | D |
04 May 2022 17:09 | VRTX | VERTEX PHARMACEUTICALS INC | BHATIA SANGEETA N. | Director | 02 May 2022 | Sale | 91 | 261.91 | 23,834 | D |
04 May 2022 17:09 | VRTX | VERTEX PHARMACEUTICALS INC | BHATIA SANGEETA N. | Director | 02 May 2022 | Sale | 80 | 260.82 | 20,866 | D |
04 May 2022 17:09 | VRTX | VERTEX PHARMACEUTICALS INC | BHATIA SANGEETA N. | Director | 02 May 2022 | Sale | 120 | 259.75 | 31,170 | D |
04 May 2022 17:09 | VRTX | VERTEX PHARMACEUTICALS INC | BHATIA SANGEETA N. | Director | 02 May 2022 | Sale | 120 | 258.9 | 31,068 | D |
04 May 2022 17:09 | VRTX | VERTEX PHARMACEUTICALS INC | BHATIA SANGEETA N. | Director | 02 May 2022 | Sale | 280 | 257.51 | 72,103 | D |
04 May 2022 17:09 | VRTX | VERTEX PHARMACEUTICALS INC | BHATIA SANGEETA N. | Director | 02 May 2022 | Sale | 40 | 255.4 | 10,216 | D |
04 May 2022 17:07 | VRTX | VERTEX PHARMACEUTICALS INC | WAGNER CHARLES F JR | EVP & Chief Financial Officer | 02 May 2022 | Sale | 3 | 264.37 | 793 | D |
04 May 2022 17:07 | VRTX | VERTEX PHARMACEUTICALS INC | WAGNER CHARLES F JR | EVP & Chief Financial Officer | 02 May 2022 | Sale | 32 | 262.06 | 8,386 | D |
04 May 2022 17:07 | VRTX | VERTEX PHARMACEUTICALS INC | WAGNER CHARLES F JR | EVP & Chief Financial Officer | 02 May 2022 | Sale | 48 | 261.15 | 12,535 | D |
04 May 2022 17:07 | VRTX | VERTEX PHARMACEUTICALS INC | WAGNER CHARLES F JR | EVP & Chief Financial Officer | 02 May 2022 | Sale | 80 | 259.45 | 20,756 | D |
04 May 2022 17:07 | VRTX | VERTEX PHARMACEUTICALS INC | WAGNER CHARLES F JR | EVP & Chief Financial Officer | 02 May 2022 | Sale | 60 | 258.21 | 15,493 | D |
04 May 2022 17:07 | VRTX | VERTEX PHARMACEUTICALS INC | WAGNER CHARLES F JR | EVP & Chief Financial Officer | 02 May 2022 | Sale | 100 | 257.18 | 25,718 | D |
04 May 2022 17:07 | VRTX | VERTEX PHARMACEUTICALS INC | WAGNER CHARLES F JR | EVP & Chief Financial Officer | 02 May 2022 | Sale | 20 | 254.87 | 5,097 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)